Newsletters - February - March 2000

Further to the news item titled "Limits Eased on Dietary Supplements" (Current Issues, January 2000), we would like to inform our readers about a subsequent statement issued by the FDA on Feb. 9 advising dietary supplement manufacturers not to make any health claims related to pregnancy on their products. The FDA will issue a Federal Register notice shortly, describing the agency's concerns and plans for future action. The agency made the move after birth defect experts protested that the dietary supplements label claims for pregnancy-related conditions posed serious risks for pregnant women and their offspring.

    VISIT US

  • Sabinsa Canada Inc.
    6800 Kitimat Road, Unit 28,
    Mississauga, ON L5N 5M1
    Canada

  • +1 905-286-6616
  • +1 437-988-1663
  • info@sabinsa.ca

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.